SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Pionyr Immunotherapeutics, Inc., a company developing first-in-class Myeloid Tuning TM antibody therapeutics that enhance the body’s anti-tumor immunity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results